Amgen, a biotechnology company, is expanding its multi-drug facility in Holly Springs with a $1 billion investment.

Spectrum Local News

United States

Biotech company 'doubles down' on Holly Springs with $1B investment

Amgen's agreement with the state could also move more than $1 million into a fund that helps rural communities.

Ad Fontes Media

Media Bias/Fact Check

abc11 Raleigh

The Walt Disney Company

Raleigh

Wake County

North Carolina

Hundreds of jobs coming to Wake County with Biotech company Amgen's expansion in Holly Springs

The plans were announced Thursday morning as state officials approved a jobs grant worth up to $6.5 million.

All Sides

Wral News

Capitol Broadcasting Company

Amgen to add 370 jobs as part of $1B investment in Holly Springs, NC officials say

Advance Publications

Liberty Media

Capital Group Companies

The Vanguard Group

Mitsubishi UFJ Financial Group

Nippon Life

Meiji Yasuda Life

Norinchukin Bank

Resona Holdings

Sumitomo Mitsui Trust Holdings

Masayoshi Son

JPMorgan Chase

Citigroup

Baillie Gifford

Amgen is investing $1 billion for a second factory in North Carolina after already allocating more than half a billion dollars for a separate facility in the state.
The latest factory in Holly Springs will ...

Endpoints News

Amgen deepens roots in North Carolina with latest $1B factory build

Amgen said today it will raise its biomanufacturing investment in Holly Springs, NC, to $1.5 billion, by establishing a second drug substance manufacturing plant there—thanks in part to nearly $5 million in economic subsidies from North Carolina. The second plant is projected to cost $1 billion. It comes two years after Amgen broke ground on its first Holly Springs biomanufacturing facility, a $550 million drug substance manufacturing plant that…

GEN - Genetic Engineering and Biotechnology News…

Amgen Raises NC Investment to $1.5B with Plans for Second Plant

The two partners disclosed study results supporting an approval application for their drug dato-dxd. Elsewhere, Agenus cut spending and the U.S. PTO withdrew a controversial proposed patent rule.

biopharmadive.com

AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B

Amgen is investing $1bn to build a second drug substance manufacturing facility in North Carolina - increasing planned investment to the area.

European Medical Journal

Amgen expands biomanufacturing footprint in North Carolina

To establish a second drug substance manufacturing facility in Holly Springs.

contractpharma.com

Amgen Invests $3B to Expand Mfg. Facility in North Carolina

Biotechnology firm Amgen announces $1bn manufacturing expansion in Holly Springs will add engineering jobs

BioProcess International

Biotechnology firm Amgen announces $1bn manufacturing expansion in Holly Springs

Amgen

Holly Springs, North Carolina

Holly Springs

Biotech company 'doubles down' on Holly Springs with $1B investment

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics